Directory · IE
Biotechnology Research in Ireland
A register of firms and the professionals working at them in the Biotechnology Research sector based in Ireland. Browse the public index, then filter or export on Kipplo.
Companies
132 on file
Abec
ABEC engineered solutions and services for biotech manufacturing Since 1974, ABEC has been a global leader in delivering integrated process solutions and services for manufacturing in the biopharmaceutical industry. Many of today’s leading antibody, vaccine, and recombinant protein therapies are manufactured by processes and equipment engineered, manufactured, installed and serviced by ABEC, and a majority of the world’s pharmaceutical and biotech companies are ABEC customers. ABEC’s unique value is based on long experience, complete in-house capabilities, a custom, flexible approach, and long-term credibility. Whether building new capacity or improving existing facilities, ABEC’s turn-key solutions reduce overall cost and time to market while delivering maximum productivity. For more information, please visit or email info@abec.com Interested in a career at ABEC? Learn more about our open positions at
501 to 1000 staff
Gossamer Bio
Gossamer Bio is a clinical-stage biopharmaceutical company focused on the development and commercialization of seralutinib for the treatment of pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH-ILD). Our goal is to enhance the lives of people living with rare diseases.
51 to 200 staff
Biomarin Pharmaceutical Inc
Founded in 1997, BioMarin is a global biotechnology company dedicated to transforming lives through genetic discovery. The company develops and commercializes targeted therapies that address the root cause of the genetic conditions that it seeks to treat, helping to better the lives of those struggling with rare genetic disease. BioMarin discoveries have led to eight first or best-in-class commercial treatments and a pipeline of multiple product candidates applying the same science-driven, patient-forward approach to broader group of genetic disorders. The more innovative solutions developed, the more lives BioMarin can impact. Recruitment Fraud Alert Notice Please be aware of fraud or scams from individuals, organizations and/or internet sites claiming to represent BioMarin in recruitment activities. We have an established recruitment process which is required for all posted positions by BioMarin prior to issuing an offer of employment. This BioMarin process requires formal interviews conducted live with personnel representing BioMarin and never requires payments or fees from job applicants. BioMarin does not conduct interviews via texting tools such as RingCentral. In the event you receive a suspicious email message about recruiting on behalf of BioMarin, unless it’s from a BioMarin authorized recruiting partner, do not provide any personal information or pay any fees. Qualified and interested candidates should apply to current openings directly through this BioMarin website. BioMarin accepts no responsibility for any costs or charges incurred as a result of fraudulent activity. If you have lost money or provided your personal identifying information, please contact your bank and report the matter to the FBI via We would also suggest you notify your local police department and monitor your credit. We appreciate your interest in BioMarin & encourage you to visit http://careers.biomarin.com/career-areas to review job opportunities.
1001 to 5000 staff
Biocryst Pharmaceuticals, Inc
BioCryst Pharmaceuticals is a global biotechnology company with a deep commitment to improving the lives of people living with hereditary angioedema (HAE) and other rare diseases. We leverage our expertise in structure-guided drug design to develop first-in-class or best-in-class oral small-molecule and protein therapeutics to target difficult-to-treat diseases. We are a commercial-stage biotech company headquartered in Durham, North Carolina. Our Discovery Center of Excellence is rooted in Birmingham, Alabama, with many other regional offices around the world. As world leaders in structure-guided drug design, we draw on the strengths and expertise of all our colleagues—from those of us in the field or behind the scenes in our labs, to others based in home offices and around the globe. To view our LinkedIn community guidelines, please visit
501 to 1000 staff
Nibrt National Institute For Bioprocessing Research And Training
The National Institute for Bioprocessing Research and Training (NIBRT) is a global centre of excellence for training and research in bioprocessing. NIBRT is located in a world class facility in Dublin, Ireland. This facility is purpose built to closely replicate a modern bioprocessing plant with state of the art equipment. NIBRT also hosts CONCEPT, a core facility for early-stage biotherapy development, providing state-of-the-art solutions for next-generation therapeutic research, including biologics, cell, gene and RNA therapies. https://concept-nibrt.ie/ Please contact us to discover how NIBRT can address your bioprocessing training and research needs. training@nibrt.ie Twitter Account @NIBRT_
51 to 200 staff
Amryt Pharma
Amryt Pharma was acquired by Chiesi Farmaceutici S.p.A.(“Chiesi”) April 12, 2023. Amryt is a biopharmaceutical company focused on developing and delivering innovative new treatments to help improve the lives of patients with rare and orphan diseases. Amryt Pharma's online communities are open to the public. Anything posted to our social networks may be seen and read by everyone. We cannot be responsible for views expressed other than our own. By posting on Amryt Pharma's social media pages, you grant us the right to use or reproduce your content. We welcome questions and commentary, including constructive feedback and differing opinions, but please remember to be both relevant and respectful with what you post. We do not tolerate harassment, abuse, or threats to others. We reserve the right to remove any posts that don’t adhere to our guidelines and to block anyone who violates them repeatedly. Learn more about our community guidelines here: https://amrytpharma.com/social-media-guidelines/
201 to 500 staff
Bioatlantis
BioAtlantis provides sustainable technologies to enhance plant, animal and human health. It leads the scientific-based movement to reduce the world’s dependence on agrochemicals and avoid the overuse of antibiotics in animals which is causing a build-up of resistance to antibiotics in humans. SuperFifty Prime enhances the tolerance of crops to extreme weather events such as drought, excess heat, cold and salinity via, a priming technology while offering growers a Return On Sustainable Investment (ROSI) of 3:1.
51 to 200 staff
Systems Biology Ireland
SBI established in 2009 under the Science Foundation Ireland CSET programme has successfully developed an integrated mathematical modelling and experimental research programme focusing on the design of new therapeutic approaches to cancer, degenerative and inflammatory diseases based on a systems level, mechanistic understanding of cellular signal transduction networks. SBI is one of the few centres in Europe with the necessary in house expertise, technologies and capabilities to apply systems biology approaches to mammalian models. It’s recognition internationally within the field of systems biology led to the Centre’s invited participation in three large European funded consortia initiatives in 2012 namely the ITFoM, CASyM and ISBE, the last of which is included on the ESFRI 2010 Roadmap. Research carried out at the Centre, significantly contributed to two successful large EU-FP7 multi-partner health proposals namely ASSET and PRIMES, both of which are coordinated by SBI and have a funding allocation in the region of €12 million each. Since its inception in 2009, SBI has built up a highly skilled international work-force of approx. 80 staff, many of which have secured independent funding and contributed to SBI’s impressive track record to date
51 to 200 staff
Equilume
Performance lighting solutions for horses. Leaders in innovative lighting solutions to maximise performance and reproductive efficiency for horses.
11 to 50 staff
Micron Agritech
Welcome to Micron Agritech, where we're revolutionising the future of animal health. Our innovative platform equips the agriculture industry with advanced tools to analyse, track, and safeguard livestock and equine health with unparalleled precision—all from a convenient mobile interface. From identifying infections to proactive health management, our cutting-edge analysis tools empower vets and animal owners to ensure the well-being of their animals while driving sustainability in agriculture. Join us as we lead the charge towards a healthier, more resilient future for animals, one data point at a time. Follow our page for updates on our groundbreaking solutions and insights into the transformative power of data-driven animal health management.
11 to 50 staff
Carrick Therapeutics
Carrick Therapeutics is pioneering a portfolio of unique, first in class, cancer treatments that target driver mechanisms of the most aggressive forms of cancer, and which will be tailored to an individual patient’s tumour. Targeting the molecular pathways that drive the most aggressive and resistant forms of cancer will transform the way that cancer is treated and have a major impact on the lives of cancer patients. By linking a network of clinicians and scientists in internationally leading research institutes and hospitals, Carrick will streamline the introduction of these ground-breaking cancer therapies into the clinic, thus serving cancer patients around the world.
1 to 10 staff
Cellix
Cellix is dedicated to providing our customers with easy-to-use benchtop instruments for cell analysis, cell sorting and customised solutions for microfluidics. Cellix was spun-out from Trinity College Dublin in 2006 when we launched our VenaFlux and Microfluidic Solutions ranges. Over the years, we have expanded our product offerings supporting our customers in several therapeutic areas including thrombosis, oncology, atherosclerosis, inflammation, infectious diseases, biofilm culture, stem cell research, sickle cell disease, asthma, and allergies. Our Microfluidic Solutions include set-ups for droplet generation, organ-on-chip and VOC analysis. More recently, Cellix's multi-disciplinary team of engineers and scientists have been developing our Inish Solutions range: microfluidic label-free impedance cell analysis and sorting. We want our customers to succeed so we are demystifying flow cytometry and bringing them simple, easy-to-use cell analysis and sorting for every lab, not just core facilities.
11 to 50 staff
Columbus Instruments Behavior, Physiology, & Metabolism
Since 1970, Columbus Instruments has been an advanced manufacturer of behavior and physiology instrumentation.
11 to 50 staff
Plusvital
Plusvital is a leader in equine science and nutrition, dedicated to empowering equine performance through scientifically advanced supplements and services. Founded in 1975 and headquartered in Ireland, Plusvital harnesses the latest scientific research to develop supplement products that optimize equine health, performance, and welfare. With a commitment to innovation, quality, and excellence, Plusvital is trusted by top riders, trainers, and breeders worldwide
11 to 50 staff
Eirnabio
Harnessing the Power of Translatomics. Enabling Bioinnovations. Contact us at info@eirnabio.com.
11 to 50 staff
Precisionbiotics
PrecisionBiotics® develops clinically-proven natural supplements that provide One-in-a-Trillion solutions to many modern health problems. For 25 years, we have researched probiotic cultures and enzymes and their impact on the human microbiome, identifying unique bacterial strains that target specific health conditions, such as IBS and stress. Our products are clinically tested, backed by data and validated to the highest scientific standards. They are also based on unique consumer insights. Our purpose is to help people make the right choice about the proven natural supplements that target individual health conditions. Our mission is to unlock and share the natural power of the human microbiome and empower people to take control of their health.
11 to 50 staff
Psc Biotech Corporation
Founded in 1996, PSC Biotech Corporation was created with the vision of providing life science companies unmatched support. PSC Biotech Corporation serves clients in more than 35 countries worldwide through professional services consulting, cloud-based software solutions, pharmaceuticals contract manufacturing, life science investment consulting, and metrology services. PSC Biotech Corporation has three unique divisions within the parent company – each representing one of our areas of expertise: PSC Biotech, PSC Software, and BioTechnique™. Additionally, PSC Asia and PSC Biotech Ltd represent PSC Biotech Corporation in Asia and Europe, respectively. Together, these divisions enable us to meet the ever-changing needs of our clients with a commitment to excellence and superior quality. To learn more, visit our website.
201 to 500 staff
Megazyme
Megazyme is a global leader in analytical reagents, enzymes and assay kits. From our headquarters in Bray, Megazyme develops, manufactures and supplies products for laboratories around the world. Our products have found applications in a diverse range of industries, including food and beverages, biofuel, animal feed, wine and brewing, dairy, and cereals. Cutting-edge research is at the core of Megazyme’s product development. Our novel test methods and analysis sets are developed by scientists for scientists, and we are the sole worldwide producer for a number of industry-standard products. Many of the analytical methods developed by Megazyme have been validated as official standard methods, recommended by the relevant regulatory bodies and scientific associations following rigorous inter-laboratory evaluations. These stamps of approval demonstrate that we can deliver accurate, reliable, quantitative and easy-to-use test methods that meet our customers’ exacting specifications. We are proud to receive ongoing recognition from business awards bodies internationally. Megazyme became part of NEOGEN in January 2021. NEOGEN Corporation develops and markets products dedicated to food and animal safety. The company’s Food Safety Division markets dehydrated culture media and diagnostic test kits to detect foodborne bacteria, natural toxins, genetic modifications, food allergens, drug residues, plant diseases and sanitation concerns. NEOGEN’s Animal Safety Division markets a complete line of diagnostics, veterinary instruments, veterinary pharmaceuticals, nutritional supplements, disinfectants and rodenticides. Megazyme is always on the lookout for new talent. Our success is dependent on our people. We believe that each employee, irrespective of role or position, contributes directly to the quality of our products and services. Interested in joining our dedicated, dynamic and innovative team, where every employee counts? Enquire by sending your CV to: careers@megazyme.com
11 to 50 staff
Theratechnologies Inc
Theratechnologies is a specialty biopharmaceutical company focused on the commercialization of innovative therapies that have the potential to redefine standards of care. We currently market prescription products for people with HIV in the United States. Our research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, oncology and rare and niche populations.
51 to 200 staff
Vle Therapeutics
Vaccines, CGTs, and other advanced therapeutics are taking too long to reach patients. Scientists want to move faster, but external manufacturers prioritize ‘contracts’ over the need for innovation and speed in GMP manufacturing. The promise of patient-focused partnerships remains out of reach until now.*Speed through Science* VLE is led by the brightest scientific minds and powered by iACHIEVE© and BioACHIEVE© our digital and process science platforms. For every medicine, we redefine CMC, tech transfer, and GMP operations through digitization and scientific excellence creating a new frontier for medicine acceleration and a new state-of-the-art for GMP manufacturing.*Patient-Focused Partnerships* We constantly strive to understand the unique clinical and CMC landscape of every medicine we work on, enabling us to deliver the manufacturing breakthroughs our partners need to achieve audacious supply chain goals that truly serve patients.*Digital First GMP* Our expertise in manufacturing science and GMP operations is accentuated by our first-in-class digital strategy – iACHIEVE©. By digitizing our process, analytical and manufacturing science breakthroughs we can deliver medicines with the speed that patients deserve and the precision regulators demand.
51 to 200 staff
Bd-Gencell Biosystems
GenCell Biosystems is a developer of innovative biological testing instruments based in Limerick, Ireland. Founded in 2011, currently employs over 60 people. GenCell Biosystems was acquired by BD (Becton, Dickinson and Company) on Oct 13, 2014 BD-GenCell Biosystems provides biology with robust, high performance systems to perform analysis faster and at lower cost than is currently possible. BD-GenCell’s platform Composite Liquid Cell technology mirrors nature by performing tests within inert synthetic cells. These Composite Liquid Cells are an ideal environment to perform biological chemistry. Commercial instrument configurations include: • Library preparation for next generation sequencing • High throughput genotyping • High throughput DNA extraction • Live cell screening for compound testing To-date we have partnered with a number of established biotech companies to develop instrumentation for multiple applications. The company also collaborates with various worldwide universities to continuously develop innovative technologies.
51 to 200 staff
Brandon Bioscience
Brandon Bioscience is a marine biotechnology company based in Tralee, Co. Kerry that specialise in the production of precision biostimulants. We are driven by science, inspired by nature, and committed to improving crop yields and quality while respecting the environment. With 25 years of experience, we are the trusted experts in plant biostimulants and pioneers in sustainable agriculture.
11 to 50 staff
Hooke Bio Ltd
Hooke Bio Ltd. was founded in 2014 by Professor Mark Davies at Stokes Laboratories, University of Limerick (UL), a research center which has a rich history of microfluidic entrepreneurship. Hooke Bio spun out from UL in 2017 and has been based in Shannon, Co. Clare, Ireland since 2019. To date, Hooke Bio have been awarded up to 12M in investment from a combination of private, angel and public funds. A portion of this has come from the prestigious European Innovation Council (EIC) Accelerator funding of which Hooke was awarded 5.7M (blended finance) in 2023. Hooke Bio recently launched their service option with hardware launch of their Mera system scheduled for late 2025. Most recently in Dec 2024, Hooke were successful in the DTIF Call 7 with Relevium Medical and the University of Galway on the RestOAre project worth €4.6M. Hooke Bio also have 3 patents protecting their technology as well as a freedom to operate. The company has consistently been supported from investors (Boole Investment Syndicate and Irrus Investments) and the Western Development Commission. The Hooke Bio premises in Clare consists of Engineering Labs (optics/microfluidics/electronic), a class II biological laboratory and a fully kitted out toolroom.
11 to 50 staff
Tmc Pharma Services Ltd
TMC is a global pharma services company, partnering with small to mid-sized biotech and pharma companies to accelerate drug development timelines and maximise value across the full product lifecycle. We provide end-to-end support - from early stage clinical development to clinical execution, market access and drug commercialisation. Our integrated pharma services are delivered by cross-functional experts with extensive knowledge across regulatory, clinical development, medical services, pharmacovigilance and quality specialities. Whether you're advancing a rare disease treatment, pioneering an advanced therapeutic modality or preparing for market entry in the EU and UK, TMC is the pharma services company with the agility, insight and infrastructure to make it happen.
501 to 1000 staff
